Glenmark recalls 1,200 bottles of generic hypertension drug in US

Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA). The New Jersey-based arm of the drug firm is recalling 1,200 bottles of Trandolapril and Verapamil Hydrochloride extended-release tablets, as per the latest Enforcement Report of the US health regulator.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DmP2uJE
via IFTTT